Johnson & Johnson

JNJ

$162.78

+12.0% (1 year change)

Avg closing price

Price range

Market Cap

$422 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$21.1 Billion

Total revenue in the last quarter.

Net Income

$3.55 Billion

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$6.36

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$3.94 (2.46%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

24.84x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$5.84 Billion

Earnings before interest expenses and taxes in the last quarter.

Employees

0

The number of full time employees.

Revenue & Earnings

Balance Sheet

Johnson & Johnson

News

AstraZeneca vs Pfizer vs Johnson & Johnson: Which vaccine is cheapest?

AstraZeneca vs Pfizer vs Johnson & Johnson: Which vaccine is cheapest?

The African Union has secured a massive consigment of vaccines this week: Here's what they had to pay to AstraZeneca, Pfizer, and Johnson & Johnson.

TheSouthAfrican TheSouthAfrican, about 19 hours ago
How founder of family-friendly clean skincare brand got her big idea

How founder of family-friendly clean skincare brand got her big idea

Beauty entrepreneur Kimberley Ho is building the next Johnson & Johnson – natural skincare label Evereden, which offers products safe for babies and children, and targets clean-beauty-conscious new...

South China Morning Post South China Morning Post, 2 days ago
Vaccine ETFs outperform Nasdaq and S&P500; offer diversified exposure to Covid

Vaccine ETFs outperform Nasdaq and S&P500; offer diversified exposure to Covid

Covid-19, Covid-19 vaccine, exchange traded fund (ETF), Biotechnology stocks, Moderna, Pfizer Inc, AstraZenaca, BioNTech, Sinopharm, CanSinoBiologics Inc, Johnson & Johnson, Novavax

The Edge Singapore The Edge Singapore, 6 days ago